213 related articles for article (PubMed ID: 10591711)
1. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.
Philipp M; Kohnen R; Hiller KO
BMJ; 1999 Dec; 319(7224):1534-8. PubMed ID: 10591711
[TBL] [Abstract][Full Text] [Related]
2. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
Woelk H
BMJ; 2000 Sep; 321(7260):536-9. PubMed ID: 10968813
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
Szegedi A; Kohnen R; Dienel A; Kieser M
BMJ; 2005 Mar; 330(7490):503. PubMed ID: 15708844
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
Vorbach EU; Arnoldt KH; Hübner WD
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
6. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial.
Uebelhack R; Gruenwald J; Graubaum HJ; Busch R
Adv Ther; 2004; 21(4):265-75. PubMed ID: 15605620
[TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine.
Czekalla J; Gastpar M; Hübner WD; Jäger D
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():86-8. PubMed ID: 9342766
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.
Vorbach EU; Hübner WD; Arnoldt KH
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S19-23. PubMed ID: 7857502
[TBL] [Abstract][Full Text] [Related]
12. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.
Schrader E
Int Clin Psychopharmacol; 2000 Mar; 15(2):61-8. PubMed ID: 10759336
[TBL] [Abstract][Full Text] [Related]
13. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
14. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.
Katona C; Bercoff E; Chiu E; Tack P; Versiani M; Woelk H
J Affect Disord; 1999 Oct; 55(2-3):203-13. PubMed ID: 10628889
[TBL] [Abstract][Full Text] [Related]
15. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
16. Use of hypericum as antidepressant. Valid measure of antidepressant efficacy in primary care is needed.
Thornett A
BMJ; 2000 Apr; 320(7242):1141; author reply 1143. PubMed ID: 10775231
[No Abstract] [Full Text] [Related]
17. Comparison of St John's Wort and imipramine. Study design casts doubt on value of St John's wort in treating depression.
Spira JL
BMJ; 2001 Feb; 322(7284):493; author reply 494. PubMed ID: 11222432
[No Abstract] [Full Text] [Related]
18. Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.
Gastpar M; Singer A; Zeller K
Pharmacopsychiatry; 2006 Mar; 39(2):66-75. PubMed ID: 16555167
[TBL] [Abstract][Full Text] [Related]
19. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial.
Akhondzadeh S; Kashani L; Fotouhi A; Jarvandi S; Mobaseri M; Moin M; Khani M; Jamshidi AH; Baghalian K; Taghizadeh M
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):123-7. PubMed ID: 12551734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
